The effect of human factor H on immunogenicity of meningococcal native outer membrane vesicle vaccines with over-expressed factor H binding protein.
about
Molecular basis of host specificity in human pathogenic bacteriaProtein Crystallography in Vaccine Research and DevelopmentHuman factor H (FH) impairs protective meningococcal anti-FHbp antibody responses and the antibodies enhance FH bindingMeningococcal disease and the complement system.Heterogeneity in rhesus macaque complement factor H binding to meningococcal factor H binding protein (FHbp) informs selection of primates to assess immunogenicity of FHbp-based vaccines.Mutant Native Outer Membrane Vesicles Combined with a Serogroup A Polysaccharide Conjugate Vaccine for Prevention of Meningococcal Epidemics in Africa.A native outer membrane vesicle vaccine confers protection against meningococcal colonization in human CEACAM1 transgenic mice.A Mutant Library Approach to Identify Improved Meningococcal Factor H Binding Protein Vaccine Antigens.A Newly-Identified Polymorphism in Rhesus Macaque Complement Factor H Modulates Binding Affinity for Meningococcal FHbp.Functional Analysis of the Human Antibody Response to Meningococcal Factor H Binding ProteinImpact of Reducing Complement Inhibitor Binding on the Immunogenicity of Native Neisseria meningitidis Outer Membrane Vesicles.Binding of Complement Factor H (FH) Decreases Protective Anti-FH Binding Protein Antibody Responses of Infant Rhesus Macaques Immunized With a Meningococcal Serogroup B Vaccine.Design of meningococcal factor H binding protein mutant vaccines that do not bind human complement factor H.A meningococcal vaccine antigen engineered to increase thermal stability and stabilize protective epitopes.Effect of complement Factor H on anti-FHbp serum bactericidal antibody responses of infant rhesus macaques boosted with a licensed meningococcal serogroup B vaccineImpaired Immunogenicity of Meningococcal Neisserial Surface Protein A in Human Complement Factor H Transgenic Mice.A meningococcal NOMV-FHbp vaccine for Africa elicits broader serum bactericidal antibody responses against serogroup B and non-B strains than a licensed serogroup B vaccineBacillus anthracis Spore Surface Protein BclA Mediates Complement Factor H Binding to Spores and Promotes Spore PersistenceImportance of inhibition of binding of complement factor H for serum bactericidal antibody responses to meningococcal factor H-binding protein vaccinesDoes binding of complement factor H to the meningococcal vaccine antigen, factor H binding protein, decrease protective serum antibody responses?Enhanced protective antibody to a mutant meningococcal factor H-binding protein with low-factor H binding.Meningococcal factor H-binding protein vaccines with decreased binding to human complement factor H have enhanced immunogenicity in human factor H transgenic mice.Portrait: coincidences, convergences and opportunities.The Long Road to an Effective Vaccine for Meningococcus Group B (MenB).Neisseria meningitidis factor H-binding protein fHbp: a key virulence factor and vaccine antigen.There Is a Method to the Madness: Strategies to Study Host Complement Evasion by Lyme Disease and Relapsing Fever SpirochetesSome Gram-negative Lipoproteins Keep Their Surface Topology When Transplanted from One Species to Another and Deliver Foreign Polypeptides to the Bacterial Surface.
P2860
Q26864388-C51C063B-C487-4544-8DB0-6B3E4F56AEADQ28087528-9CD615E6-BBB6-4A83-A58E-2FB687FAE23AQ34237895-64D05315-E56B-446C-8CE2-488A0F24BE98Q34376170-732AEF28-562C-42FE-997B-5D6CD336F1F4Q34592926-ECA0655F-A139-4018-BB2E-BD11BB7F0AB5Q34785389-80A63462-9085-442A-BF47-2431F2335D39Q35181636-8AF0C8C1-BC53-48E0-82C7-153C000C2649Q35658277-0F669760-D302-4C8B-B22B-DCFC966D6081Q35748972-6D01B18C-3C80-4284-B26C-3FD1C5BC8616Q35777766-0CCA2BE0-B254-4DC8-9CAF-F47882AF7395Q35922195-A6922A69-FBD2-444E-83BB-ED4889E6BD13Q35965207-6232CE78-2D9C-4B77-88F4-440DA03F2421Q36211092-DD4D0D6F-08EC-43FE-B41B-7D34BD212111Q36354851-64FEB69D-6128-4510-A29B-81B9611F41CCQ36385023-F4C3C7C5-BB2B-48D3-9DBA-CDC6603E853DQ36513433-D38D9A86-5E98-4D37-9F61-B8A5ECB74F0CQ36521563-F25D2D59-5B9D-41BC-A39D-9F82BDCE3363Q37008156-3BC1CCA1-4F77-4449-BB80-C323431C3A38Q37037083-0ACB7871-3BC5-4AD3-9F86-4A723EC6BB97Q37124721-FC36FC7E-DB14-49DB-8A30-F631BB4B06E7Q37277250-E0C696F9-BC5E-4C4B-B14E-563324E326B7Q37401146-2FAD6D77-191F-4EB4-B4BB-CB8439775AA6Q37505447-16716785-27E2-4892-85E9-08DEF2DC94D7Q38335257-0CAA6219-FA8F-4F16-8820-6E17DBB80FF2Q38363907-47BD167B-4A5C-4F7B-A752-92EBEE5E7C80Q39182985-58B54F85-2B43-4DF7-82A5-0574EED38640Q40955783-D2EA9D16-956B-41B6-B619-5EECCBFD5B4E
P2860
The effect of human factor H on immunogenicity of meningococcal native outer membrane vesicle vaccines with over-expressed factor H binding protein.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The effect of human factor H o ...... ssed factor H binding protein.
@ast
The effect of human factor H o ...... ssed factor H binding protein.
@en
The effect of human factor H o ...... ssed factor H binding protein.
@nl
type
label
The effect of human factor H o ...... ssed factor H binding protein.
@ast
The effect of human factor H o ...... ssed factor H binding protein.
@en
The effect of human factor H o ...... ssed factor H binding protein.
@nl
prefLabel
The effect of human factor H o ...... ssed factor H binding protein.
@ast
The effect of human factor H o ...... ssed factor H binding protein.
@en
The effect of human factor H o ...... ssed factor H binding protein.
@nl
P2093
P2860
P1433
P1476
The effect of human factor H o ...... ssed factor H binding protein.
@en
P2093
Dan M Granoff
Emily M Braga
Jutamas Shaughnessy
Peter T Beernink
Rolando Pajon
Sanjay Ram
P2860
P304
P356
10.1371/JOURNAL.PPAT.1002688
P577
2012-05-10T00:00:00Z